Chemotherapy (CHT) adjuvant strategies and reasons for choice in breast cancer (BC) patients (pts): results from the national oncological research observatory on adjuvant therapy (NORA)

被引：0
|
作者：
Mustacchi, G. [1 ]
Cazzaniga, M. [1 ]
Pronzato, P. [1 ]
Di Costanzo, F. [1 ]
Floriani, I. [1 ]
De Matteis, A. [1 ]
机构：
[1] Univ Trieste, Trieste, Italy
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90665-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] Hormone adjuvant strategies in breast cancer (BC) patients (pts): results from the National Oncological Research observatory on Adjuvant therapy (NORA)
    Cazzaniga, M.
    Pronzato, P.
    Mustacchi, G.
    Di Costanzo, F.
    Floriani, I.
    De Matteis, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 72 - 72
  • [2] Application of newer adjuvant treatments for node positive (N+) breast cancer (BC) patients (pts) in Italian centers. Results of the NORA (National Oncological Research Observatory on Adjuvant Therapy in breast cancer) Study.
    Pronzato, P
    Cazzaniga, ME
    Mustacchi, G
    Di Costanzo, F
    de Matteis, A
    Porcu, L
    Danova, M
    Salvadori, B
    Chetri, MC
    Rizzo, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 97S - 97S
  • [3] ECOG stage influences the choice of adjuvant therapy independently of ER status in surgically resected breast cancer (BC) patients (PTS). Results of the NORA study
    不详
    BREAST, 2005, 14 : S35 - S35
  • [4] Cognitive and sexual side effects of adjuvant therapies in early breast cancer patients (BC PTS). Results from the NORA study
    Cazzaniga, M. E.
    Mustacchi, G.
    Pronzato, P.
    De Matteis, A.
    Di Costanzo, F.
    Rulli, E.
    Latini, L.
    Barni, S.
    Merlano, M.
    Floris, C.
    ANNALS OF ONCOLOGY, 2007, 18 : 51 - 51
  • [5] ADJUVANT MEDICAL STRATEGIES AND PATTERNS OF RELAPSE IN BREAST CANCER (BC) PATIENTS: THE NORA PROJECT
    Cazzaniga, M. E.
    Mustacchi, G.
    De Matteis, A.
    Pronzato, P.
    Di Costanzo, F.
    Porcu, L.
    Floriani, I.
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [6] Switching from tamoxifen (TAM) to aromatase inhibitors (AIs) in the adjuvant treatment of breast cancer (BC) patients (pts). Results from the NORA study
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 158 - 158
  • [7] Peculiarities of adjuvant treatment in young patients (pts) with early breast cancer: results from the "NORA" study
    De Matteis, Andrea
    Cazzaniga, Marina E.
    Mustacchi, Giorgio
    Pronzato, Paolo
    Di Costanzo, Francesco
    Porcu, Luca
    ANNALS OF ONCOLOGY, 2004, 15 : 67 - 67
  • [8] Capecitabine as adjuvant therapy for elderly breast cancer (BC) patients (pts): a pilot study
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 154 - 154
  • [9] Effect of adjuvant chemotherapy (CRx) on the cognitive function of older patients (pts) with breast cancer (BC): Results from a prospective study.
    Hurria, A
    Rosen, C
    Zuckerman, E
    Holland, J
    Panageas, K
    Witmer, M
    van Gorp, W
    Norton, L
    Hudis, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 779S - 779S
  • [10] Triple negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA study
    Mustacchi, Giorgio
    Beano, Alessandra
    Fabi, Alessandra
    Livi, Lorenzo
    Bernardo, Antonio
    Riccardi, Ferdinando
    Marchetti, Paolo
    Garrone, Ornella
    Diodati, Lucrezia
    Biganzoli, Laura
    Giordano, Monica
    Turletti, Anna
    Blasi, Livio
    Milani, Andrea
    Natoli, Clara
    Riemma, Marta
    D'Alonzo, Alessia
    Arpino, Grazia
    Pronzato, Paolo
    Cazzaniga, Marina E.
    CANCER RESEARCH, 2020, 80 (04)
12345